In recent years, a large amount of evidence has shown that cGAMP, as an agonist of interferon-stimulating gene protein STING, can activate innate immunity and release pro-inflammatory cytokines such as interferon to inhibit the proliferation and metastasis of malignant tumor cells such as colorectal cancer, breast cancer, and melanoma. Here, STING1 is linked to cancer.